Atea Pharmaceuticals Inc

NASDAQ:AVIR

3.14

-0.16 (-4.85%)

6:27:44 PM EDT: $3.20 +0.06 (+1.91%)

Atea Pharmaceuticals Inc Stock, NASDAQ:AVIR

225 Franklin Street, Suite 2100, Boston, Massachusetts 02110

United States of America

Phone: +1.857.284.8891

Number of Employees: 56

http://www.ateapharma.com

Description

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.